Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #4,431 to #4,480.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Sulci (anatomy) [145 bytes]
  2. (hist) Phylostratum [145 bytes]
  3. (hist) Albuginea [145 bytes]
  4. (hist) Rostral [145 bytes]
  5. (hist) Morning headaches [145 bytes]
  6. (hist) Abdominal bruit surgery [145 bytes]
  7. (hist) Eye neoplasm cost-effectiveness of therapy [145 bytes]
  8. (hist) Ventricular remodeling surgery [145 bytes]
  9. (hist) Cyclosporiasis classification [145 bytes]
  10. (hist) Clindamycin hydrochloride [145 bytes]
  11. (hist) Erythromycin [145 bytes]
  12. (hist) Mesoblastic nephroma historical perspective [145 bytes]
  13. (hist) Hemophilia B laboratory findings [145 bytes]
  14. (hist) Erysipelas biopsy [145 bytes]
  15. (hist) Metronidazole [146 bytes]
  16. (hist) Decapeptide [146 bytes]
  17. (hist) Prototypic promoter [146 bytes]
  18. (hist) Tabellaria spp. [146 bytes]
  19. (hist) Lateral condyle [146 bytes]
  20. (hist) Extensor carpi radialis [146 bytes]
  21. (hist) Prednisone contraindications [146 bytes]
  22. (hist) Risperidone contraindications [146 bytes]
  23. (hist) Calcitonin contraindications [146 bytes]
  24. (hist) Tricuspid Stenosis Vital signs [146 bytes]
  25. (hist) Trench mouth electrocardiogram [146 bytes]
  26. (hist) Calcified ductus arteriosus [146 bytes]
  27. (hist) Vasculitis historical perspective [146 bytes]
  28. (hist) Triamcinolone [146 bytes]
  29. (hist) Testosterone [146 bytes]
  30. (hist) Ciprofloxacin [146 bytes]
  31. (hist) Hemophilia B history and symptoms [146 bytes]
  32. (hist) Hemophilia B physical examination [146 bytes]
  33. (hist) Hemophilia B secondary prevention [146 bytes]
  34. (hist) Tracheobronchomalacia epidemiology and demographics [146 bytes]
  35. (hist) Tracheobronchomalacia cost-effectiveness of therapy [146 bytes]
  36. (hist) Hantavirus pulmonary syndrome secondary prevention [146 bytes]
  37. (hist) Struma ovarii future or investigational therapies [146 bytes]
  38. (hist) Protein energy malnutrition cost-effectiveness of therapy [146 bytes]
  39. (hist) Incidentaloma future or investigational therapies [146 bytes]
  40. (hist) Med hub 1 fellowship placements [146 bytes]
  41. (hist) CQS [147 bytes]
  42. (hist) TGA [147 bytes]
  43. (hist) Ranitidine contraindications [147 bytes]
  44. (hist) Hepatitis E electrocardiogram [147 bytes]
  45. (hist) Hepatitis E chest x ray [147 bytes]
  46. (hist) Hepatitis E MRI [147 bytes]
  47. (hist) Hepatitis E surgery [147 bytes]
  48. (hist) Pulmonary artery sclerosis [147 bytes]
  49. (hist) Hypothyroidism CT [147 bytes]
  50. (hist) Dysphagia future or investigational therapies [147 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)